AL
Therapeutic Areas
Aspect Analytics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Target Discovery & Validation Solution | Broad (Oncology, Autoimmune, etc.) | Early Discovery |
| Mechanism of Action (Preclinical) Solution | Broad | Preclinical Research |
| PK/PD & Drug Distribution Solution | Broad (Quantifying compound effects) | Preclinical/Translational |
| Clinical Research & Stratification Solution | Broad (Patient cohort refinement) | Clinical Research |
| Academic & Consortium Research Platform | Fundamental & Translational Research | Research |
| CRO Analysis & Standardization Service | Client-sponsored drug programs | All Phases |
Leadership Team at Aspect Analytics
SV
Steven Verhoeven
Chief Executive Officer (CEO)
MC
Marc Claesen, PhD
Co-founder and Chief Technical Officer (CTO)
TM
Thomas Moerman
Co-founder & Senior Developer
NV
Nico Verbeeck, PhD
Co-founder & Director of Mass Spectrometry Imaging
HP
Heath Patterson, PhD
Director of Spatial Biology Bioinformatics
TL
Thierry Loones
Director of Product Management
SB
Sanja Bajovic
Director of Scientific Engagements
PK
Paul Klyvis
Head of AI/ML
DD
Dries De Peuter
Senior DevOps Engineer
HV
Herman Verrelst
Chairman of the board